178 related articles for article (PubMed ID: 28379068)
1. Impact of an integrated oral chemotherapy program on patient adherence.
Morgan KP; Muluneh B; Deal AM; Amerine LB
J Oncol Pharm Pract; 2018 Jul; 24(5):332-336. PubMed ID: 28379068
[TBL] [Abstract][Full Text] [Related]
2. Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.
Middendorff G; Elsey R; Lounsbery B; Chadwell R
J Oncol Pharm Pract; 2018 Jul; 24(5):371-378. PubMed ID: 28509613
[TBL] [Abstract][Full Text] [Related]
3. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
4. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
Barnes E; Zhao J; Giumenta A; Johnson M
J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
[TBL] [Abstract][Full Text] [Related]
5. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
6. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
7. Effect of a Smart Pill Bottle and Pharmacist Intervention on Medication Adherence in Patients with Multiple Myeloma New to Lenalidomide Therapy.
Mauro J; Mathews KB; Sredzinski ES
J Manag Care Spec Pharm; 2019 Nov; 25(11):1244-1254. PubMed ID: 31663462
[TBL] [Abstract][Full Text] [Related]
8. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
[No Abstract] [Full Text] [Related]
9. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
10. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
11. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
13. Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program.
Deutsch S; Koerner P; Miller RT; Craft Z; Fancher K
J Oncol Pharm Pract; 2016 Feb; 22(1):68-75. PubMed ID: 25301744
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
[TBL] [Abstract][Full Text] [Related]
15. Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.
Looney B; Crumb J; White S; Jones G; Moore RP; Choi L; Zuckerman AD; Whelchel K
J Manag Care Spec Pharm; 2024 May; 30(5):465-474. PubMed ID: 38701029
[TBL] [Abstract][Full Text] [Related]
16. Impact of a Pharmacist-Led Hypertension Management Program for Oral Chemotherapy in a Specialty Pharmacy Setting.
Wang G; Truong H; Dang R
J Oncol Pharm Pract; 2023 Jan; 29(1):52-59. PubMed ID: 34738845
[TBL] [Abstract][Full Text] [Related]
17. Low-health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications.
Yeung DL; Alvarez KS; Quinones ME; Clark CA; Oliver GH; Alvarez CA; Jaiyeola AO
J Am Pharm Assoc (2003); 2017; 57(1):30-37. PubMed ID: 27816544
[TBL] [Abstract][Full Text] [Related]
18. The role of the pharmacist in improving medication beliefs and adherence in cancer patients.
Birand N; Boşnak AS; Diker Ö; Abdikarim A; Başgut B
J Oncol Pharm Pract; 2019 Dec; 25(8):1916-1926. PubMed ID: 30786821
[TBL] [Abstract][Full Text] [Related]
19. Impact of a formal pharmacist-run oral antineoplastic monitoring program: A pilot study in an adult genitourinary oncology clinic.
Conliffe B; Figg L; Moffett P; Lauterwasser L; Parsons LB
J Oncol Pharm Pract; 2019 Jun; 25(4):777-786. PubMed ID: 29375014
[TBL] [Abstract][Full Text] [Related]
20. Survey of oral chemotherapy safety and adherence practices of hospitals in Spain.
Conde-Estévez D; Salas E; Albanell J
Int J Clin Pharm; 2013 Dec; 35(6):1236-44. PubMed ID: 24129581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]